The first fully-automated system for multiplex protein biomarker analysis during drug development, was introduced by Decision Biomarkers, Inc. (DBI) at the third annual Protein Biomarkers conference held in Philadelphia, PA, September 26 - 28.
The first fully-automated system for multiplex protein biomarker analysis during drug development, was introduced by Decision Biomarkers, Inc. (DBI) at the third annual Protein Biomarkers conference held in Philadelphia, PA, September 26 - 28.
